Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.
Published September 30, 2020 · Recall initiated: September 1, 2020
Summary
FDA records drug Class I recall D-1595-2020, published September 30, 2020 and initiated September 1, 2020. Recalling firm: The Protein Shoppe; Status: Terminated; Reported quantity: 21,511 tablets; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- The Protein Shoppe
- Distributor
- Nationwide in the USA
- Lot
- All lots.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAlbuterol Sulfate Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalations, Manufactured by: CatalentSeptember 30, 2020
- FDAbio aaa Alcohol en Gel Antibacterial, Alcohol al 70% Cont. Neto 480 ml bottle, Hecho en Mexico por: AAASeptember 30, 2020
- FDAZanilast+ Gel Antiseptic Hand Sanitizer (70% Ethyl Alcohol) Packaged in 25 kg bottles, Distributed by FujimuraSeptember 30, 2020
- FDANature-Throid, 1/2 Grain, 32.5 mg (Thyroid U.S.P. 1/2 gr. (32.5 mg)/Liothyronine (T3) 4.5mcg/LevothyroxineSeptember 30, 2020
- FDAZanilast+ Gel Antiseptic Hand Sanitizer (70% Ethyl Alcohol) Packaged in a) 33.8 fl oz (1.06 qt) (1L) (NDCSeptember 30, 2020
- FDANature-Throid, 3/4 Grain (48.75 mg) Thyroid U.S.P. 3/4 gr. (48.75 mg)/Liothyronine (T3) 6.75mcg/LevothyroxineSeptember 30, 2020
Questions about this recall
Was Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling. recalled?
Yes. FDA published recall D-1595-2020 on September 30, 2020. Reported hazard: Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release